Literature DB >> 4347425

Characterization of morphologic revertants of murine and avian sarcoma virus-transformed cells.

J R Stephenson, R K Reynolds, S A Aaronson.   

Abstract

Morphologic revertants which contain avian or murine sarcoma viruses have previously been isolated at low frequency from clonal lines of transformed mammalian cells. In the present study, these lines have been further characterized. They are indistinguishable from nontransformed parent cell lines with respect to parameters such as saturation density and colony formation in depleted medium or on monolayers of contact-inhibited cells. The rate of glucose uptake had also reverted to normal. The malignant potential of one of the revertant lines was examined and found to be markedly reduced compared to that of the corresponding transformed cells. The differences in the susceptibilities of revertant cells to retransformation by the same or other oncogenic viruses suggest that different cellular genes may be involved in expression of transformation by various tumor viruses.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4347425      PMCID: PMC355085     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells.

Authors:  S A Aaronson; S P Rowe
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

2.  Analysis of a functional change in membrane in the process of cell transformation by Rous sarcoma virus; alteration in the characteristics of sugar transport.

Authors:  M Hatanaka; H Hanafusa
Journal:  Virology       Date:  1970-08       Impact factor: 3.616

3.  Altered glucose transport kinetics in murine sarcoma virus-transformed BALB-3T3 clones.

Authors:  M Hatanaka; G J Todaro; R V Gilden
Journal:  Int J Cancer       Date:  1970-03-15       Impact factor: 7.396

4.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

5.  The formation of variants with a reversion of properties of transformed cells. II. In vitro formation of variants from polyoma-transformed cells.

Authors:  Z Rabinowitz; L Sachs
Journal:  Virology       Date:  1969-06       Impact factor: 3.616

6.  Basis for the acquisition of malignant potential by mouse cells cultivated in vitro.

Authors:  S A Aaronson; G J Todaro
Journal:  Science       Date:  1968-11-29       Impact factor: 47.728

7.  Stimulation of cell growth in vitro by serum with and without growth factor. Relation to contact inhibition and viral transformation.

Authors:  J L Jainchill; G J Todaro
Journal:  Exp Cell Res       Date:  1970-01       Impact factor: 3.905

8.  Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability.

Authors:  R E Pollack; H Green; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

9.  Susceptibility of human cell strains to transformation by simian virus 40 and simian virus 40 deoxyribonucleic acid.

Authors:  S A Aaronson
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

10.  Persistent infection of a rat kidney cell line with Rauscher murine leukemia virus.

Authors:  E N Rosenblum; R F Zeigel
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  12 in total

1.  Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.

Authors:  N Kuzumaki; Y Ogiso; A Oda; H Fujita; H Suzuki; C Sato; L Müllauer
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

2.  Quantitation and localization of Rous sarcoma virus-specific RNA in transformed and revertant field vole cells.

Authors:  R A Krzyzek; A F Lau; P K Vogt; A J Faras
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

3.  Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant.

Authors:  R Wisdom; I M Verma
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

4.  Temperature-sensitive cellular mutant for expression of mRNA from murine retrovirus.

Authors:  H Inoue; S Kizaka; M Yutsudo; A Hakura
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.

Authors:  M Noda; H Kitayama; T Matsuzaki; Y Sugimoto; H Okayama; R H Bassin; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth.

Authors:  J R Haynes; J R Downing
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

7.  Selection of revertants of Kirsten sarcoma virus transformed nonproducer BALB-3T3 cells.

Authors:  B Ozanne; A Vogel
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

8.  Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.

Authors:  J D Norton; F Cook; P C Roberts; J P Clewley; R J Avery
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

Authors:  M Noda; Z Selinger; E M Scolnick; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Inhibitory effect of a revertant cell on in vivo growth of its parental transformed cell line.

Authors:  P Ebbesen; L Olsson
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.